351.09
price up icon2.77%   9.47
after-market After Hours: 355.00 3.91 +1.11%
loading
Beone Medicines Ltd Adr stock is traded at $351.09, with a volume of 155.83K. It is up +2.77% in the last 24 hours and up +1.34% over the past month. Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$341.62
Open:
$347.82
24h Volume:
155.83K
Relative Volume:
0.45
Market Cap:
$38.50B
Revenue:
$4.56B
Net Income/Loss:
$-176.77M
P/E Ratio:
-204.40
EPS:
-1.7177
Net Cash Flow:
$225.30M
1W Performance:
+4.75%
1M Performance:
+1.34%
6M Performance:
+67.66%
1Y Performance:
+0.00%
1-Day Range:
Value
$346.99
$353.00
1-Week Range:
Value
$334.53
$355.30
52-Week Range:
Value
$172.67
$355.30

Beone Medicines Ltd Adr Stock (ONC) Company Profile

Name
Name
Beone Medicines Ltd Adr
Name
Phone
41-616851900
Name
Address
C/O BEONE MEDICINES I GMBH, BASEL
Name
Employee
11,000
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ONC's Discussions on Twitter

Compare ONC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ONC
Beone Medicines Ltd Adr
351.09 37.52B 4.56B -176.77M 225.30M -1.7177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.15 105.19B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
450.68 60.24B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.86 61.82B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
798.94 49.09B 3.06B 1.28B 447.35M 19.67

Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-18-25 Initiated Barclays Overweight
Apr-07-25 Initiated RBC Capital Mkts Outperform
Mar-03-25 Upgrade BofA Securities Neutral → Buy
Dec-03-24 Resumed Morgan Stanley Overweight
Sep-18-24 Initiated JMP Securities Mkt Outperform
Feb-06-24 Resumed JP Morgan Overweight
Sep-12-23 Initiated Macquarie Outperform
Aug-17-23 Initiated Jefferies Buy
Jul-17-23 Initiated Citigroup Buy
Jun-30-23 Downgrade Bernstein Outperform → Mkt Perform
Jan-12-23 Initiated Daiwa Securities Buy
Oct-13-22 Upgrade Guggenheim Neutral → Buy
Oct-13-22 Upgrade SVB Leerink Mkt Perform → Outperform
Aug-09-22 Resumed JP Morgan Overweight
Mar-17-22 Downgrade SVB Leerink Outperform → Mkt Perform
Feb-07-22 Initiated Deutsche Bank Buy
Oct-12-21 Initiated Bernstein Outperform
Oct-06-21 Upgrade CLSA Underperform → Buy
Mar-08-21 Initiated China Renaissance Buy
Mar-01-21 Downgrade CLSA Outperform → Underperform
Nov-09-20 Downgrade Ladenburg Thalmann Buy → Neutral
Nov-06-20 Downgrade Maxim Group Buy → Hold
Nov-06-20 Downgrade Piper Sandler Neutral → Underweight
View All

Beone Medicines Ltd Adr Stock (ONC) Latest News

pulisher
05:29 AM

160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World

05:29 AM
pulisher
Oct 07, 2025

Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World

Oct 07, 2025
pulisher
Oct 06, 2025

PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Oct 06, 2025
pulisher
Oct 01, 2025

14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World

Oct 01, 2025
pulisher
Oct 01, 2025

14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Sep 29, 2025
pulisher
Sep 24, 2025

BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives $336.30 Consensus PT from Brokerages - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat

Sep 23, 2025
pulisher
Sep 21, 2025

BeOne Medicines (NASDAQ:ONC) Upgraded at Zacks Research - Defense World

Sep 21, 2025
pulisher
Sep 19, 2025

BeOne Medicines (NASDAQ:ONC) Coverage Initiated by Analysts at Barclays - Defense World

Sep 19, 2025
pulisher
Sep 18, 2025

BeOne Medicines (NASDAQ:ONC) SVP Sells 10,006 Shares - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap UpHere's What Happened - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

BeOne Medicines (NASDAQ:ONC) Insider Sells $1,750,300.00 in Stock - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap Down After Insider Selling - MarketBeat

Sep 16, 2025

Beone Medicines Ltd Adr Stock (ONC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$161.81
price down icon 0.31%
$798.94
price up icon 0.20%
$106.28
price up icon 0.21%
$32.74
price up icon 0.31%
$563.86
price down icon 3.32%
Cap:     |  Volume (24h):